Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-21-037144

Director sold 3,900 shares at an average $32.55 ($126,935)

  • Director acquired 3,900 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Heyman Richard A. · Director

Table I: Non-derivative

12 lines
Date Transaction Shares Price Value Owned after D/I
2021-06-01 Exercise or conversion : show line 1 in the form +1,950 $2.95 $5,753 1,950 I
2021-06-01 Sale : show line 2 in the form −1,392 $32.15 $44,754 558 I
2021-06-01 Sale : show line 3 in the form −553 $33.61 $18,587 5 I
2021-06-01 Sale : show line 4 in the form −5 $34.67 $173 0 I
2021-06-01 Exercise or conversion : show line 5 in the form +975 $2.95 $2,876 975 I
2021-06-01 Sale : show line 6 in the form −743 $32.16 $23,896 232 I
2021-06-01 Sale : show line 7 in the form −230 $33.75 $7,762 2 I
2021-06-01 Sale : show line 8 in the form −2 $34.67 $69 0 I
Open-market sales · 3,900 sh · avg $32.55 · $126,935

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-06-01 Exercise or conversion : show line 13 in the form Stock Option (right to buy) −1,950 15,901 I
2021-06-01 Exercise or conversion : show line 14 in the form Stock Option (right to buy) −975 7,951 I
2021-06-01 Exercise or conversion : show line 15 in the form Stock Option (right to buy) −975 7,951 I
Loading xslF345X03/doc4.xml…